TACSTD2 and colorectal carcinoma: We observed that compared to CRC cases without metastasis, H3K18la was markedly increased in CRLM samples especially liver metastases, in response to their elevated TROP2 expression level (Figure 2P), revealing H3K18la as a biological effector of TROP2 and its signal in CRLM.